Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, August 19 at 2:00 PM EDT

Register Free →

Search

Top

Back to Contracts

Burn and Complex Wound Care Solutions

Active

Federal

Response Deadline10/30/2026, 04:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The contract titled Burn and Complex Wound Care Solutions seeks advanced wound care technologies specifically designed for the treatment of burns and combat-related injuries, with eligibility contingent upon exclusion criteria outlined in the final Request for Proposals. It is issued under the NAICS code 325412, indicating a focus on pharmaceutical and medical manufacturing, and is structured as a subcontract within the Department of Defense, managed by the Defense Health Agency. The opportunity was posted on August 7, 2026, with a response deadline of October 30, 2026, and performance is expected to center in Frederick, though the exact location details are unspecified. The solicitation does not designate a specific set-aside status, and all interested parties must ensure their solutions meet the technical and clinical standards required for military medical applications while adhering to any final exclusions defined in the RPP.

General Info

Burn and combat wound care tech sought under DoD subcontract, response due October 30, 2026, performance in Frederick.

Agency

Department Of Defense → Defense Health AgencyView Agency

NAICS

325412 - Pharmaceutical Preparation ManufacturingView NAICS

Place of Performance

Frederick, MD, USA

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PostedAug 7

subcontract

Response DeadlineOct 30

Submission deadline

Response Deadline

10/30/2026, 04:00:00 PM UTCin 3 months

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more

AgencyDepartment Of Defense → Defense Health Agency

ContactsNo contacts available

OfficeN/A

Organization / Agency

Department Of Defense → Defense Health Agency

View Agency Profile

Office AddressN/A

ContactsNo contact information available

Full Description

Show more

Advanced wound care technologies for burns and combat-related injuries, eligible if not explicitly excluded in final RPP.

Similar Contracts

Same NAICS industry code

Custom Organic Compound Synthesis (Non-GMP)The contract involves the custom synthesis of five small-molecule compounds, each in quantities of five grams, for use in Ewing sarcoma drug development under non-GMP research conditions. The work encompasses the full scope of organic synthesis including route design, multi-step chemical reactions, and purification to yield chemically defined products suitable for preclinical evaluation. All activities are non-GMP, meaning the compounds will not be produced under regulatory quality systems required for clinical use but rather for internal research and biological testing purposes. The effort is structured as a subcontract under the National Institutes of Health, operating through the Department of Health and Human Services, with the NAICS code 325412 indicating pharmaceutical and medicine manufacturing. The solicitation was posted on August 7, 2026, and responses are due by August 24, 2026, with no set-aside designation applied. The place of performance and point of contact details are not specified, and the work is expected to be carried out by an external research or synthesis provider aligned with the NIH’s oncology drug discovery goals.

National Institutes Of Health Olao

POSTED

about 16 hours ago

DEADLINE

High-Priority Pathogen Infection PreventionThe contract seeks preventive solutions non-vaccine approaches to combat infections caused by high-priority pathogens including Pseudomonas aeruginosa and Shigella, targeting urgent public health and defense-related threats. It is issued under the Defense Health Agency within the Department of Defense and is classified as a subcontract, with the North American Industry Classification System code 325412 indicating focus on pharmaceutical preparation manufacturing. The initiative aims to advance innovative, non-pharmaceutical interventions such as antimicrobial barriers, prophylactic agents, or environmental controls that interrupt transmission or reduce pathogen load without relying on vaccines. Responses are due by October 30, 2026, and the performance location is designated as Frederick, though the full address and point of contact details are not provided. The solicitation remains open to qualified entities capable of delivering scalable, evidence-based preventive technologies aligned with military and civilian health protection needs.

Defense Health Agency

POSTED

about 16 hours ago

DEADLINE

Non-Addictive Battlefield Pain Management SolutionsThe contract seeks the development of non-opioid analgesics or alternative pain relief technologies designed for military use in austere environments, with a focus on creating effective, non-addictive solutions that can be deployed in combat or field conditions where traditional pain management options are impractical or risky. The work must address the unique challenges of battlefield medicine, including limited resources, extreme climates, and the need for rapid, reliable pain control without the potential for dependency or misuse. The technology must be robust, easily transportable, and compatible with existing military medical protocols and equipment. The contract is structured as a subcontract under the Defense Health Agency, part of the Department of Defense, and is governed by the NAICS code 325412 for pharmaceutical preparation manufacturing. Proposals must be submitted by October 30, 2026, and performance will center in Frederick, with no specific city, state, or zip provided beyond that location. There is no set-aside classification applied to this opportunity, and while no point of contact is listed, interested parties can access additional details through the provided SAM.gov link. The initiative reflects a strategic priority to reduce reliance on opioid-based treatments in military healthcare and advance innovations that enhance soldier readiness and long-term health outcomes.

Defense Health Agency

POSTED

about 16 hours ago

DEADLINE

Government Contracting Compliance & GSA Schedule SupportThe contract solicits the supply of biotechnology reagents through existing GSA Schedule or GWAC vehicles, requiring full compliance with the Federal Acquisition Regulation for pricing and delivery terms. All offerings must leverage pre-negotiated, FAR-compliant contractual mechanisms to ensure transparency, affordability, and efficiency in procurement by the National Institutes of Health, specifically the National Institute on Drug Abuse under the Department of Health and Human Services. The NAICS code 325412 confirms the primary focus on pharmaceutical and biological product manufacturing, indicating the need for high-purity, research-grade reagents suitable for scientific and clinical applications. Responses must be submitted by August 13, 2026, and the contract is structured as a subcontract, implying the awardee will fulfill obligations under a prime contract holder rather than directly with the government. Performance is expected to align with federal supply chain standards, though no specific place of performance or set-aside criteria are provided. Compliance with GSA Schedule or GWAC terms is mandatory, ensuring that pricing remains consistent with established federal rates and that delivery timelines meet agency operational needs. The solicitation underscores the importance of proven regulatory adherence and reliable supply chain execution to support critical biomedical research activities.

National Institutes Of Health Nida

POSTED

DEADLINE

Specialty Biotech Reagent Manufacturing (dCODE Dextramer®)The contract involves the manufacture of specialized immunology reagents based on dextramer technology, specifically customizable HLA-peptide complexes equipped with fluorescent barcoding, intended for use in research and clinical applications. These reagents are designed to enable precise detection and analysis of antigen-specific T cells, supporting advancements in immunological studies and potential therapeutic development. The production must meet stringent quality and consistency standards to ensure reliability across diverse experimental and diagnostic settings, with an emphasis on scalability and customization to accommodate varying peptide and HLA combinations. This is a subcontract under the National Institutes of Health, specifically the National Institute on Drug Abuse, part of the Department of Health and Human Services, with the NAICS code 325412 indicating biological product manufacturing. The opportunity was posted on August 6, 2026, and responses are due by August 13, 2026, with no set-aside classification specified. The place of performance and other location details are not provided, indicating flexibility in where the manufacturing may occur, though all work must comply with the technical and regulatory requirements for clinical-grade reagents. The focus is squarely on advanced biotech manufacturing capabilities, emphasizing precision, reproducibility, and compliance with industry best practices for immune monitoring tools.

National Institutes Of Health Nida

POSTED

DEADLINE

Supplier of Universal 5' Gene Expression Kits

National Institutes Of Health Nida

POSTED

DEADLINE

Supplier of Feature Barcode Kits for Single-Cell Analysis

National Institutes Of Health Nida

POSTED

DEADLINE

Supplier of Chromium GEM-X Single Cell 5' Chip Kits

National Institutes Of Health Nida

POSTED

DEADLINE

Supplier of Single-Cell Library Construction Kits

National Institutes Of Health Nida

POSTED

DEADLINE

Virus-Vectored Oral Rabies Vaccine Bait – Fishmeal Polymer FormulationThe contract pertains to the supply of fishmeal polymer-based vaccine baits with part number 128425, specifically formulated as a virus-vectored oral rabies vaccine intended for targeted wildlife species. These baits are designed to deliver rabies immunization in a palatable, durable form that supports effective distribution in野外 environments, leveraging a fishmeal polymer matrix to ensure stability and attraction for target animals. The work under this subcontract is tied to efforts led by the USDA’s APHIS-Wildlife Services division to manage and reduce the spread of rabies among wildlife populations through strategic oral vaccination campaigns. The solicitation was posted on August 6, 2026, with submissions due by September 7, 2026, at 9:00 PM. The North American Industry Classification System code 325412 indicates the work falls under pharmaceutical and biological product manufacturing, underscoring the scientific and regulatory rigor expected in production. Performance is required to occur in Concord, New Hampshire, with a ZIP code of 03301, though no specific office address or point of contact is provided. The nature of the contract as a subcontract suggests it supports a broader federal wildlife health initiative, likely underpinning national or regional rabies control programs managed by the Department of Agriculture.

POSTED

DEADLINE

in about 1 month

Virus-Vectored Oral Rabies Vaccine Bait – Sachet FormulationThe contract is for the supply of coated sachet vaccine baits designated as part number 128370, specifically formulated for oral rabies vaccination of wildlife populations. These baits are intended to be distributed in targeted areas to immunize terrestrial wildlife against rabies, leveraging a virus-vectored platform to ensure effective delivery and immune response. The product is a sachet formulation designed for environmental stability and animal acceptance, with coating mechanisms to protect the vaccine until consumed. The solicitation is categorized as a subcontract under NAICS code 325412, which pertains to pharmaceutical and biological product manufacturing, indicating the technical and regulatory rigor expected in production and quality control. Delivery and performance of the vaccine baits must occur within the designated place of performance in Concord, New Hampshire, with a response deadline set for September 7, 2026, and the opportunity posted on August 6, 2026. The contracting entity is the USDA’s Animal and Plant Health Inspection Service Wildlife Services division, reflecting the federal commitment to zoonotic disease control and wildlife health management.

POSTED

DEADLINE

in about 1 month

Supply of dCODE Dextramer® Reagents (HLA-A*0201 Specificity)The contract involves the supply of peptide-loaded dCODE Dextramer® reagents designed to target the HLA-A*0201 molecule for use in T-cell detection and immune monitoring within research settings. These reagents are critical tools for identifying and quantifying antigen-specific T cells, enabling advanced immunological studies, particularly in areas such as vaccine development, infectious disease research, and cancer immunotherapy. The reagents must meet specified purity, stability, and binding affinity standards to ensure reliable and reproducible results in laboratory applications. The solicitation is structured as a subcontract under the National Institutes of Health NIDA, part of the Department of Health and Human Services, with a North American Industry Classification System code of 325412 indicating biological product manufacturing. The opportunity was posted on August 6, 2026, with a response deadline of August 13, 2026, at 7:00 PM. While no set-aside provisions or specific place of performance details are provided, the contract requires adherence to technical specifications for reagent formulation and quality control. The procurement process is managed through the SAM.gov platform, and interested parties must submit proposals before the stated deadline to be considered for award.

National Institutes Of Health Nida

POSTED

DEADLINE

More opportunities from Department Of Defense → Defense Health Agency

Same awarding agency

Emergency Bulk Gas Delivery ServicesThe contract mandates on-call emergency delivery of liquid oxygen to Landstuhl Regional Medical Center with a strict four-hour response window to avert life-threatening supply shortages. Services must be available around the clock to ensure uninterrupted medical operations, particularly in urgent care and critical care scenarios where oxygen is essential. The contractor is expected to maintain immediate operational readiness, including properly maintained equipment, trained personnel, and contingency plans to meet response time obligations regardless of weather, logistical challenges, or other disruptions. This subcontract falls under NAICS code 484220 for specialized freight trucking and is issued by the Defense Health Agency under the Department of Defense. The place of performance is exclusively at Landstuhl, Germany, with a ZIP code of 66849, indicating the delivery requirements are geographically confined to this critical military medical facility. Bids must be submitted by August 23, 2026, and the opportunity was posted on August 7, 2026, offering potential vendors a limited window to prepare competitive proposals. There is no designated set-aside category, meaning all eligible contractors may compete, and the contract's success hinges on reliability, speed, and consistent compliance with medical supply standards under high-stress conditions.

Specialized Freight (except Used Goods) Trucking, Local

POSTED

about 16 hours ago

DEADLINE

Routine Bulk Gas Delivery ServicesThe contract outlines the scheduled delivery of liquid oxygen to Landstuhl Regional Medical Center under a subcontract for routine bulk gas services, with all transportation conducted by ADR-certified hazardous materials carriers. Deliveries must adhere strictly to both the U.S.-Germany Status of Forces Agreement and applicable German host-nation regulations to ensure compliance with international and local hazardous material handling protocols. The performance location is specified as Landstuhl, Germany, with a ZIP code of 66849, confirming the operational focus on U.S. military medical facilities in the region. The contract falls under NAICS code 484220, indicating it is classified as a transportation service for hazardous materials. It is managed by the Defense Health Agency under the Department of Defense and was posted on August 7, 2026, with a response deadline of August 23, 2026.

Specialized Freight (except Used Goods) Trucking, Local

POSTED

about 16 hours ago

DEADLINE

Bulk Storage Tank Rental and MaintenanceThe contract involves the rental, maintenance, telemetry monitoring, and certification of a single ASME-certified vertical bulk liquid oxygen storage tank located at Landstuhl, Germany, specifically at the Landstuhl Regional Medical Center. Services include ongoing operational support to ensure the tank remains fully functional and compliant with safety and regulatory standards, with telemetry monitoring providing real-time data on tank conditions such as pressure, temperature, and fill levels. Certification activities must align with ASME codes and applicable medical and hazardous material handling regulations to guarantee uninterrupted oxygen supply for critical patient care. Emergency response support is a mandatory component, requiring immediate availability to address leaks, pressure deviations, equipment failures, or other incidents that could threaten facility operations or personnel safety. The contract is structured as a subcontract under the Defense Health Agency, part of the Department of Defense, with a NAICS code of 423830 indicating wholesale trade of medical and dental equipment. Performance is exclusively tied to the Landstuhl location with a ZIP code of 66849, and the solicitation, posted on August 7, 2026, requires proposals to be submitted by August 23, 2026. While no set-aside provisions or point of contact details are specified, the requirement is mission-critical, prioritizing reliability, rapid response, and continuous compliance to support medical operations in a high-demand military healthcare environment.

Industrial Machinery and Equipment Merchant Wholesalers

POSTED

about 16 hours ago

DEADLINE

Medical Bulk Liquid Oxygen SupplyThe contract pertains to the supply of medicinal-grade liquid oxygen with a minimum purity of 99.5%, meeting stringent pharmacopeial standards including USP, DAB, and EUAB. The oxygen must be delivered FOB destination to Landstuhl Regional Medical Center with the zip code 66849, ensuring seamless integration into the medical facility’s clinical operations. Automatic refill triggers are mandated to maintain uninterrupted supply, eliminating the risk of stockouts during critical patient care scenarios. The contract is classified as a subcontract under NAICS code 325120 and is issued by the Defense Health Agency under the Department of Defense. The solicitation was posted on August 7, 2026, with responses due by August 23, 2026, and performance is concentrated at the specified medical facility in Landstuhl.

Industrial Gas Manufacturing

POSTED

about 16 hours ago

DEADLINE

Battlefield Medical Diagnostics and DevicesThe contract seeks the development of portable, rapid diagnostic tools specifically designed for use in pre-hospital military environments, aiming to enable immediate medical assessment and decision-making on the battlefield. These devices must be rugged, easy to use under extreme conditions, and capable of delivering accurate diagnostic results without reliance on laboratory infrastructure, supporting frontline medics and combat lifesavers in time-critical scenarios. The technology is expected to address gaps in battlefield triage and early detection of trauma, infection, or chemical exposure, with an emphasis on minimal training requirements and compatibility with existing military medical protocols. The contract is classified as a subcontract under NAICS code 339112, indicating a focus on medical and surgical instrument manufacturing, and is managed by the Defense Health Agency within the Department of Defense. The place of performance is centered in Frederick, and interested parties must submit responses by October 30, 2026. While no set-aside provisions are specified, the requirement targets innovative solutions that can be rapidly integrated into field operations, with performance expectations aligned to mission-critical readiness and reliability standards. Technical proposals must demonstrate feasibility, scalability, and the ability to function reliably in austere and high-stress environments.

Surgical and Medical Instrument Manufacturing

POSTED

about 16 hours ago

DEADLINE

Regenerative Medicine for Tissue RepairThe contract titled Regenerative Medicine for Tissue Repair is a subcontract issued by the Defense Health Agency under the Department of Defense to advance research into regenerative therapies aimed at accelerating tissue repair in combat-related injuries. The focus is on innovative approaches such as stem cell applications and biomaterials designed to restore function and reduce recovery time for severe battlefield trauma. The opportunity was posted on August 7, 2026, with a response deadline of October 30, 2026, at 4:00 PM, providing potential applicants a limited window to submit proposals. The North American Industry Classification System code 541715 indicates this effort falls under research and development in the life sciences, specifically in the biomedical field. Performance of the work is expected to be conducted in Frederick, Maryland, aligning with existing military and medical research infrastructure in the region. This subcontract represents a strategic Department of Defense initiative to bridge cutting-edge medical science with urgent battlefield medical needs.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

about 16 hours ago

DEADLINE

Mental Health Help-Seeking Barrier ReductionThe contract seeks the development of innovative tools, programs, or technologies aimed at reducing stigma and promoting early mental health intervention among military service members. Focused on removing barriers to care, the initiative requires solutions that are practical, scalable, and tailored to the unique culture and operational demands of the armed forces. The work is intended to improve mental health outcomes by increasing awareness, encouraging help-seeking behaviors, and integrating support systems into everyday military life. Submitted under the NAICS code 621340, which pertains to mental health and substance abuse centers, this subcontract is managed by the Defense Health Agency under the Department of Defense. Proposals must be submitted by October 30, 2026, with performance expected to center on Frederick, Maryland. The effort aligns with broader DoD priorities to enhance readiness through proactive mental health support, demanding solutions that are evidence-based, culturally competent, and capable of measuring real-world impact on service member wellbeing.

Offices of Physical, Occupational and Speech Therapists, and Audiologists

POSTED

about 16 hours ago

DEADLINE

Musculoskeletal Injury Treatment OptimizationThe contract seeks innovative prototypes aimed at enhancing the treatment, recovery, and rehabilitation of musculoskeletal injuries frequently experienced by military personnel. Focused on practical, scalable solutions, the initiative targets advancements in medical technology or therapeutic methods that can improve outcomes for service members, with an emphasis on real-world applicability within military healthcare settings. The work is to be performed in Frederick, and the project is categorized under NAICS code 339112, indicating a focus on medical equipment and supplies manufacturing. This is a subcontract opportunity issued by the Defense Health Agency under the Department of Defense, with proposals due by October 30, 2026, and the opportunity was posted on August 7, 2026. There is no set-aside designation specified, and the contract is open to qualified subcontractors capable of delivering advanced, evidence-based solutions tailored to the unique physical demands and recovery needs of military personnel.

Surgical and Medical Instrument Manufacturing

POSTED

about 16 hours ago

DEADLINE

Anesthesia Solutions for Austere EnvironmentsThe contract seeks the development of safe, portable anesthesia delivery systems tailored for use in austere battlefield environments or Role 1 and Role 2 medical settings, where traditional medical infrastructure is limited or unavailable. The focus is on creating reliable, compact, and easy-to-operate anesthesia equipment that ensures patient safety and consistent delivery of anesthetic agents under challenging conditions, including extreme temperatures, power limitations, and high-stress operational scenarios. The solution must prioritize portability, durability, and rapid deployment without compromising clinical efficacy or reducing the need for highly specialized personnel during use. Submitted proposals must align with the NAICS code 339112, indicating a focus on medical equipment and supplies manufacturing, and are expected to meet rigorous military and medical standards for performance and safety. The opportunity is structured as a subcontract, with responses due by October 30, 2026, and performance expected to center around Frederick, Maryland. The Defense Health Agency within the Department of Defense is managing the solicitation with the goal of enhancing medical readiness and sustaining care capabilities in forward-deployed and resource-constrained environments. There is no set-aside designation specified, and while no point of contact is listed, interested parties are directed to the provided SAM.gov link for further details and submission requirements.

Surgical and Medical Instrument Manufacturing

POSTED

about 16 hours ago

DEADLINE

Pathogen-Agnostic Sepsis CountermeasuresThe contract centers on the research and prototype development of pathogen-agnostic countermeasures for sepsis, targeting treatments or diagnostics effective against multiple infectious agents including Pseudomonas aeruginosa and Shigella. This initiative seeks to identify novel therapeutic or diagnostic platforms that function independently of the specific causative pathogen, addressing the critical challenge of sepsis management in heterogeneous infection scenarios. The work is funded under a subcontract arrangement by the Defense Health Agency within the Department of Defense, reflecting a strategic focus on advancing military and civilian medical readiness through innovative biomedical solutions. The project is tied to NAICS code 541715, categorizing it under research and development in the physical, engineering, and life sciences. The opportunity was posted on August 7, 2026, with a response deadline of October 30, 2026, and the performance location is designated as Frederick. While no set-aside provisions or point of contact details are provided, the emphasis on broad-spectrum effectiveness underscores the need for scalable, broadly applicable technologies that can rapidly respond to complex, multi-pathogen sepsis cases. The contract aims to accelerate the transition from concept to prototype, prioritizing solutions with the potential for immediate deployment in clinical and operational settings.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

about 16 hours ago

DEADLINE

Blast Exposure and Traumatic Brain Injury (TBI) SensorsThe contract seeks the design and development of wearable or deployable sensors capable of monitoring blast exposure and providing real-time assessment of traumatic brain injury risk. The goal is to create advanced sensor systems that can detect and quantify blast events, translate the data into actionable physiological indicators, and offer immediate feedback to personnel and medical teams to support rapid intervention and clinical decision-making. These sensors must be suitable for use in operational environments, durable under extreme conditions, and capable of integration with existing military personnel systems. The effort is classified as a subcontract under NAICS code 334510, relating to semiconductor and other electronic component manufacturing, and is managed by the Defense Health Agency under the Department of Defense. Proposals must be submitted by October 30, 2026, with performance expected to take place in Frederick. The solicitation does not specify a set-aside status or point of contact, and the technical requirements emphasize innovation in sensor technology, data accuracy, real-time processing, and field readiness for use by military personnel exposed to blast hazards.

Electromedical and Electrotherapeutic Apparatus Manufacturing

POSTED

about 16 hours ago

DEADLINE